Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
900.65
0.75 (0.08%)
BSENSE

Dec 19

BSE+NSE Vol: 30.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "900.65",
    "chg": 0.75,
    "chgp": "0.08%",
    "dir": 1,
    "prev_price": "899.90",
    "mcapval": "11,143.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03Q201024",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "30.96 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sees Revision in Market Evaluation Amidst Challenging Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3762207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLife_mojoScore_3762207.png",
        "date": "2025-12-18 10:10:41",
        "description": "Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. This adjustment comes amid subdued financial trends and technical indicators, highlighting the challenges faced by the company in a competitive and evolving industry landscape."
      },
      {
        "title": "Alivus Life Sciences Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-faces-bearish-momentum-amid-technical-downturn-3762009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3762009.png",
        "date": "2025-12-18 08:15:10",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in technical momentum as various indicators signal a bearish trend. The stock’s recent price movements and technical parameters suggest a cautious outlook amid broader market dynamics."
      },
      {
        "title": "Alivus Life Sciences Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-sees-mixed-technical-signals-amid-price-momentum-shift-3759562",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3759562.png",
        "date": "2025-12-16 08:17:51",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of price momentum and indicator signals. Recent market data reveals a transition in trend dynamics, with mixed signals from widely followed technical indicators such as MACD, RSI, and moving averages, underscoring a cautious market stance towards the stock."
      },
      {
        "title": "Alivus Life Sciences Falls to 52-Week Low Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-stock-falls-to-52-week-low-amidst-market-pressure-3751833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_priceRelatedfactors_3751833.png",
        "date": "2025-12-08 16:05:47",
        "description": "Alivus Life Sciences has reached a 52-week low, with its stock price touching an intraday low of ₹847.5, marking a significant decline in the Pharmaceuticals & Biotechnology sector. This movement places the stock just 3.66% above its lowest price in the past year, reflecting ongoing pressures within the market and the company’s recent performance metrics."
      },
      {
        "title": "Alivus Life Sciences Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-faces-bearish-momentum-amid-technical-downturn-3743041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3743041.png",
        "date": "2025-12-03 08:08:57",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as reflected by recent technical indicators. The stock’s movement over the past weeks and months reveals a cautious market stance, with several technical parameters signalling a bearish trend. This article analyses the evolving technical landscape of Alivus Life Sciences and places its performance in the context of broader market movements."
      },
      {
        "title": "Alivus Life Sciences Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-technical-momentum-shifts-amid-mixed-market-signals-3740410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3740410.png",
        "date": "2025-12-02 08:12:19",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish trend, underscoring nuanced changes in price dynamics and technical indicators that investors should carefully consider."
      },
      {
        "title": "Alivus Life Sees Revision in Market Assessment Amidst Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-downgraded-to-sell-by-marketsmojo-amid-weak-financial-trends-3733129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlivusLife_mojoScore_3733129.png",
        "date": "2025-11-27 10:06:18",
        "description": "Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent performance trends and sector dynamics. The company’s assessment metrics have been adjusted following a period of subdued financial growth and technical indicators signalling caution."
      },
      {
        "title": "Why is Alivus Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-fallingrising-3727145",
        "imagepath": "",
        "date": "2025-11-25 01:43:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Comparison</strong></p>\n<p>Alivus Life’s stock has experienced a notable decline over the past week, falling by 5.22%, significantly underperforming the Sensex, which remained nearly flat with a marginal 0.06% gain. Over the last month, the stock also declined by 2.90%, while the Sensex advanced by 0.82%. Year-to-date, the stock has lost 9.28% of its value, contrasting sharply with the Sensex’s 8.65% gain. The disparity is even more pronounced over the last year, with Alivus Life posting a negative return of 14.46% against the Sensex’s positive 7.31%.</p>\n<p>These figures highlight a persistent underperformance trend, suggesting that investors have been cautious about the stock amid broader market gains. Despite the company’s impressive three-year return o..."
      },
      {
        "title": "Alivus Life Sciences Faces Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-faces-bearish-momentum-amid-technical-downturn-3723903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlivusLifeScien_technicaldot_3723903.png",
        "date": "2025-11-24 08:06:04",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum with technical indicators signalling a predominantly bearish trend. Recent market data reveals a nuanced picture of the stock’s performance, highlighting challenges amid broader sector dynamics and market conditions."
      }
    ],
    "total": 241,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alivus Life Sciences Ltd has declared 250% dividend, ex-date: 01 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available